Enhanced bactericidal effect of ceftriaxone drug encapsulated in nanostructured lipid carrier against gram-negative Escherichia coli bacteria: drug formulation, optimization, and cell culture study
Abstract Background Ceftriaxone is one of the most common types of antibiotics used to treat most deadly bacterial infections. One way to alleviate the side effects of medication is to reduce drug consumption by changing the ordinary drug forms into nanostructured forms. In this study, a nanostructu...
Main Authors: | Sahar Ebrahimi, Nafiseh Farhadian, Mohammad Karimi, Mohsen Ebrahimi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Antimicrobial Resistance and Infection Control |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13756-020-0690-4 |
Similar Items
-
Ceftriaxone induced drug rash with eosinophilia and systemic symptoms
by: Vivek S Guleria, et al.
Published: (2014-01-01) -
Ceftriaxone Drug Utilization Evaluation (DUE) at Prince Abdulaziz Bin Moussae’ed Hospital, Arar, Kingdom of Saudi Arabia
by: Muhammad Jan Shamsur Rehman, et al.
Published: (2019-12-01) -
Drug Use Evaluation of Ceftriaxone in Ras-Desta Memorial General Hospital, Ethiopia
by: Muhammed OS, et al.
Published: (2020-09-01) -
Evaluation of ceftriaxone-sulbactam-disodium edetate adjuvant combination against multi-drug resistant Gram-negative organisms
by: Shilpi Gupta, et al.
Published: (2020-12-01) -
Severe drug-induced immune hemolysis due to ceftriaxone
by: Ravi C Dara, et al.
Published: (2020-01-01)